Company Information

CIN
Status
Date of Incorporation
06 July 2007
State / ROC
Hyderabad / ROC Hyderabad
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2023
Paid Up Capital
2,877,670
Authorised Capital
5,000,000

Directors

Sashi Kiran Kode
Sashi Kiran Kode
Director/Designated Partner
almost 3 years ago
Ratna Kumari Kode
Ratna Kumari Kode
Director
over 18 years ago

Past Directors

Ravikant Marella
Ravikant Marella
Director
about 15 years ago
Shekhar Gupta
Shekhar Gupta
Director
almost 17 years ago
Deepak Harikrishnan
Deepak Harikrishnan
Director
almost 17 years ago

Registered Trademarks

D2l D2 L Pharma Research Solutions

[Class : 42] Providing Drug Discovery Services, Providing Clinical Services, Activity Testing, Preclinical Development, Formulation Development, Carring On Global Standard Research Stand Support To Enhance Indaian Drug Research, Carrying On R & D Activities Relating To Biopharmaccutical And Biotechnology Products, Manufacture And Sell All Biologicals, Vaccines, Drugs

Hcp Ecosystem D2 L Pharma Research Solutions

[Class : 42] Computer Programs Including Downloadable Software, Applications, Computer Operating Programs, Web Pages, Providing Access To Advertising And Directory Services Relating To Pharmaceutical Products, Pharmaceutical Professionals, Drug Discovery And Creating A Platform For Relationship Management Solutions

Charges

2 Crore
30 April 2020
Union Bank Of India
2 Crore
30 April 2020
Others
0
30 April 2020
Others
0
30 April 2020
Others
0